phenyl-n-tert-butylnitrone has been researched along with rotenone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Floyd, RA; Hensley, K; Jaffrey, F; Maidt, ML; Pye, QN; Robinson, KA; Stewart, CA | 1 |
| Baudry, M; Fonck, C | 1 |
| Chamorro, B; Chioua, M; Diez-Iriepa, D; Fernández, I; García-Vieira, D; Gonzàlez-Nieto, D; Hadjipavlou-Litina, D; Iriepa, I; López-Muñoz, F; Marco-Contelles, J; Martínez-Murillo, R; Merás-Sáiz, B; Oset-Gasque, MJ | 1 |
3 other study(ies) available for phenyl-n-tert-butylnitrone and rotenone
| Article | Year |
|---|---|
Interaction of alpha-phenyl-N-tert-butyl nitrone and alternative electron acceptors with complex I indicates a substrate reduction site upstream from the rotenone binding site.
Topics: Animals; Binding Sites; Biphenyl Compounds; Brain; Cyclic N-Oxides; Hydrogen Peroxide; Mitochondria; NAD; NAD(P)H Dehydrogenase (Quinone); Nitroblue Tetrazolium; Nitrogen Oxides; Onium Compounds; Oxidation-Reduction; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Rotenone; Succinic Acid | 1998 |
Rapid reduction of ATP synthesis and lack of free radical formation by MPP+ in rat brain synaptosomes and mitochondria.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine Triphosphate; Animals; Antioxidants; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cyclic N-Oxides; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Free Radicals; In Vitro Techniques; Male; Mazindol; Mitochondria; Neostriatum; Nitrogen Oxides; Organometallic Compounds; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Rotenone; Salicylates; Subcellular Fractions; Synaptosomes; Uncoupling Agents | 2003 |
Synthesis, antioxidant properties and neuroprotection of α-phenyl-tert-butylnitrone derived HomoBisNitrones in in vitro and in vivo ischemia models.
Topics: Animals; Apoptosis; Brain Ischemia; Cell Line, Tumor; Cyclic N-Oxides; Disease Models, Animal; Drug Evaluation, Preclinical; Free Radical Scavengers; Glucose; Infarction, Middle Cerebral Artery; Lipid Peroxidation; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Neuroblastoma; Neurons; Neuroprotection; Neuroprotective Agents; Nitrogen Oxides; Oligomycins; Oxygen; Rotenone | 2020 |